Exelixis, Inc. (EXEL)
NASDAQ·Healthcare·Biotechnology
$68.73
-5.57%
Mkt Cap $16.64B
Analyst Ratings
Buy
3
Hold
12
Sell
0
Price Target (65 analysts)
$51.78
Range $46.00 – $56.00
Implied Upside
-24.7%
Consensus $51.78 vs current $68.73
NASDAQ·Healthcare·Biotechnology
$68.73
-5.57%
Mkt Cap $16.64B
Buy
3
Hold
12
Sell
0
Price Target (65 analysts)
$51.78
Range $46.00 – $56.00
-24.7%
Consensus $51.78 vs current $68.73